Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Neuroprotection' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Neuroprotection Drugs, Markets and Companies |
May 2009 | £2440 | 100 % |
|
Parkinson's Disease - Evidence Of Neuroprotection Essential To Progress Treatment Dynamics Stakeholder Insight |
December 2007 | £7600 | 92 % |
|
Neurodegenerative Diseases Next-Generation Drugs for Four Major Disorders |
December 2008 | £2290 | 35 % |
|
Pipeline Insight: Acute Stroke Commercial Risk Offsets High Unmet Need |
May 2008 | £6000 | 19.95 % |
|
Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better Healthcare |
October 2007 | £7600 | 15.75 % |
|
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics 2009-2023 |
January 2009 | £1499 | 15.4 % |
|
Nitric Oxide Therapeutics, Markets and Companies |
May 2009 | £1710 | 15.4 % |
|
Pipeline Insight: Parkinson's Disease and Restless Legs Syndrome Reformulations set to drive near-term growth |
August 2006 | £8695 | 14.7 % |
|
Alzheimer's disease New drugs, markets and companies |
December 2008 | £1710 | 12.6 % |
|
Alzheimer Disease New Drugs, Markets and Companies |
May 2009 | £1710 | 12.25 % |
|
Parkinson's Disease Market analysis and forecasts 2008-2012, 2017 & 2022 |
January 2008 | £1499 | 8.4 % |
|
Drug Delivery in Central Nervous System Diseases Technologies,Markets and Companies |
May 2009 | £1525 | 6.65 % |
